Aurora Cannabis Inc. (ACB) vs AC Immune S.A. (ACIU)

A side-by-side comparison of Aurora Cannabis Inc. and AC Immune S.A. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ACB vs ACIU

growth of $100 · dividends reinvested · last 10y
ACB -97.3% (-30.2%/yr)ACIU -84.8% (-17.2%/yr)ACIU compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020182020202220242026$3$15
ACB ACIU

ACB vs ACIU: by the numbers

  • •ACB is the larger company ($285M vs $259M market cap).
  • •Both run net losses; ACB's is the smaller (-38.13% vs -249.94% net margin).
  • •ACB grew revenue faster over the past five years (1.68% vs -23.70% CAGR).

Metrics side by side

Valuation

MetricACBACIU
P/S ratio1.3711.92
P/B ratio0.775.94

Profitability

MetricACBACIU
Gross margin42.62%100.00%
Operating margin-14.55%-1927.32%
Net margin-38.13%-249.94%
ROE-21.41%-124.67%
ROIC-15.69%-89.43%

Growth (annualized)

MetricACBACIU
Revenue CAGR (5Y)1.68%-23.70%
Total return CAGR (5Y)-42.83%-16.03%

Frequently asked

Which has grown faster, ACB or ACIU?
Over the past five years, ACB grew revenue faster — ACB at a 1.68% CAGR versus ACIU at -23.70%.
How have ACB and ACIU total returns compared?
Over the past 10 years, ACB delivered -30.23% and ACIU delivered -16.61% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.